Cole Werble
Sometimes, it's tough for pharma execs to rein in their exuberance about the big new market awaiting the industry on...
Keeping Up a Dour Countenance on the Verge of a Big Market
Don’t let the public pronouncements of pain for pharma from healthcare reform confuse you. Big pharma has had the expansion of health insurance and finding deep pockets to cover the uninsured as its major goal for years. Pharma execs and policy people are trying to sound worried; it is hard.